100 related articles for article (PubMed ID: 15722626)
1. Pharmacokinetics of the antineoplastic drug mitomycin C in regional chemotherapy using the aortic stop flow technique in advanced pancreatic carcinoma.
Meyer F; Ridwelski K; Gebauer T; Grote R; Martens-Lobenhoffer J; Lippert H
Chemotherapy; 2005 Mar; 51(1):1-8. PubMed ID: 15722626
[TBL] [Abstract][Full Text] [Related]
2. Results of regional chemotherapy using the aortic stop-flow technique in advanced pancreatic carcinoma.
Meyer F; Gebauer T; Grote R; Martens-Lobenhoffer J; Ridwelski K; Lippert H
Surg Today; 2006; 36(2):155-61. PubMed ID: 16440163
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: a phase II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Caterino GP; Di Giuro G; Amicucci G
Eur J Surg Oncol; 2007 Feb; 33(1):72-8. PubMed ID: 17166688
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcome.
Pohlen U; Rieger H; Kunick-Pohlen S; Berger G; Buhr HJ
Anticancer Res; 2007; 27(1B):667-74. PubMed ID: 17348458
[TBL] [Abstract][Full Text] [Related]
5. Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers.
Strocchi E; Iaffaioli RV; Facchini G; Mantovani G; Ricci S; Cavallo G; Tortoriello A; D'Angelo R; Formato R; Rosato G; Fiore F; Iaccarino V; Petrella G; Memoli B; Santangelo M; Camaggi CM
Eur J Surg Oncol; 2004 Aug; 30(6):663-70. PubMed ID: 15256242
[TBL] [Abstract][Full Text] [Related]
6. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C.
Sugarbaker PH; Stuart OA; Carmignani CP
Cancer Chemother Pharmacol; 2006 May; 57(5):703-8. PubMed ID: 16096789
[TBL] [Abstract][Full Text] [Related]
8. Curative and palliative aspects of regional chemotherapy in combination with surgery.
Müller H; Hilger R
Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres.
Rump AF; Woschée U; Theisohn M; Fischbach R; Heindel W; Lackner K; Klaus W
Eur J Clin Pharmacol; 2002 Oct; 58(7):459-65. PubMed ID: 12389068
[TBL] [Abstract][Full Text] [Related]
10. Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer.
Müller H
Eur J Surg Oncol; 2002 Mar; 28(2):165-71. PubMed ID: 11884052
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
12. [Technique and pathophysiology of isolated hypoxic perfusion of the abdomen].
Petrowsky H; Heinrich S; Janshon G; Staib-Sebler E; Poloczek Y; Gog C; Oremek G; Lorenz M
Zentralbl Chir; 1999; 124(9):833-9. PubMed ID: 10544490
[TBL] [Abstract][Full Text] [Related]
13. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics.
de Lima Vazquez V; Stuart OA; Mohamed F; Sugarbaker PH
Cancer Chemother Pharmacol; 2003 Aug; 52(2):108-12. PubMed ID: 12759776
[TBL] [Abstract][Full Text] [Related]
14. Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer.
Gutman M; Abu-Abid S; Sorkine P; Inbar M; Lev D; Chen Z; Oron D; Chaitchik S; Klausner JM
Cancer; 1996 Sep; 78(5):1125-30. PubMed ID: 8780553
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
16. Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer.
Lorenz M; Petrowsky H; Heinrich S; Janshon G; Staib-Sebler E; Poloczek Y; Gog C; Oremek G; Encke A
Eur J Surg Oncol; 1998 Dec; 24(6):542-7. PubMed ID: 9870731
[TBL] [Abstract][Full Text] [Related]
17. Regional chemotherapy for advanced pancreatic carcinoma.
Bayar S; Unal E; Tez M; Kocaoglu H; Demirci S; Akgul H
Hepatogastroenterology; 2003; 50(50):550-2. PubMed ID: 12749270
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic variations during thoracic and abdominal stop-flow regional chemotherapy.
Varrassi G; Guadagni S; Ciccozzi A; Marinangeli F; Pozone T; Piroli A; Marsili I; Paladini A
Eur J Surg Oncol; 2004 May; 30(4):377-83. PubMed ID: 15063890
[TBL] [Abstract][Full Text] [Related]
19. Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trial.
van Ijken MG; van Etten B; Guetens G; de Bruijn EA; Ten Hagen TL; Wiggers T; Eggermont AM
Eur J Surg Oncol; 2005 Oct; 31(8):897-904. PubMed ID: 16084053
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of mitomycin C after resection of peritoneal carcinomatosis and intraperitoneal chemohyperthermic perfusion.
Cerretani D; Nencini C; Urso R; Giorgi G; Marrelli D; De Stefano A; Pinto E; Cioppa T; Nastri G; Roviello F
J Chemother; 2005 Dec; 17(6):668-73. PubMed ID: 16433199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
